Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$310.19 - $376.2 $1,861 - $2,257
-6 Reduced 46.15%
7 $2,000
Q2 2021

Aug 11, 2021

SELL
$262.71 - $351.17 $20,228 - $27,040
-77 Reduced 85.56%
13 $4,000
Q1 2021

May 13, 2021

BUY
$285.92 - $355.13 $25,732 - $31,961
90 New
90 $28,000
Q4 2018

Feb 13, 2019

SELL
$281.08 - $444.25 $147,285 - $232,787
-524 Closed
0 $0
Q3 2018

Oct 31, 2018

BUY
$354.53 - $449.75 $29,780 - $37,779
84 Added 19.09%
524 $236,000
Q2 2018

Aug 03, 2018

BUY
$278.07 - $446.21 $18,352 - $29,449
66 Added 17.65%
440 $180,000
Q1 2018

May 08, 2018

BUY
$192.49 - $295.85 $71,991 - $110,647
374 New
374 $108,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Harvest Fund Management Co., LTD Portfolio

Follow Harvest Fund Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Fund Management Co., LTD with notifications on news.